User:Mirandatripodi/New article

This article has been written as per Wikipedia guidelines (http://en.wikipedia.org/wiki/Wikipedia:BFAQ#COMPANY) when trying to request an article be written 'It may be helpful to create a draft of an article in a user subpage'

This article is aimed to replace the incorrect redirect set in place for 'Mayne Pharma' - http://en.wikipedia.org/wiki/Mayne_Pharma'''. Please note my association with Mayne Pharma - see http://en.wikipedia.org/wiki/User:Mirandatripodi .'''

This article has been requested at http://en.wikipedia.org/wiki/Wikipedia:Requested_articles/Business_and_economics/Businesses_and_organizations#M

Mayne Pharma International Pty Ltd (Mayne Pharma) is an oral drug delivery pharmaceutical company that specializes in the development and manufacture of pharmaceuticals (reference http://www.ondrugdelivery.com/publications/Oral%202010/Mayne.pdf). A technology driven company, Mayne Pharma competes in the following markets:


 * Branded generic product
 * Specialty generic product (generics with high barriers to competition)
 * Improved chemical entity (ICE) and
 * Value added active pharmaceutical ingredients (APIs).

With expertise spanning 40 years in the drug delivery systems field and developing global products, Mayne Pharma’s capabilities encompass the use of novel and patent protected technologies and proprietary knowledge to solve a range of oral drug delivery challenges.

Based in Salisbury, South Australia, Mayne Pharma is well equipped to develop and manufacture oral, controlled-release and dermaceutical formulations for both its own product pipeline and external customers (reference http://www.bioinnovationsa.com.au/resources/103/bionews_Oct-Nov05.pdf).

In 2009, Mayne Pharma was purchased by HalcyGen Pharmaceuticals Ltd. Currently, the company continues to trade as Mayne Pharma International, a wholly owned subsidiary of HalcyGen Pharmaceuticals Ltd (reference - http://www.theage.com.au/business/halcygen-raises-profile-after-mayne-pharma-purchase-20090925-g6en.html).

Key Products
 * Doryx (reference https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-CMI-03487-3)
 * Astrix
 * Kadian
 * Eryc (reference https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-CMI-02152-3)
 * Magnoplasm